Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.94NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GK.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.62NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.3.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JV.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XCYNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EK.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HV.1.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HV.1.6.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EF.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BU.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.34NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CJ.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.6.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CM.7.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.3.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FA.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EE.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.72NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBJ.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CK.2.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.86 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.7 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.12 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.7.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.1.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.390NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
N.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.319NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BG.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JF.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.572NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.397NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17723.5South Korea
Q.3 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.523NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.116 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.38 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.595.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.340NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used